Effect of selenium compound (selol) on the opioid activity in vincristine induced hyperalgesia

Neuroendocrinology Letters

Volumn 29, Issue 4, 2008, Pages 552-557

  Bujalska, Magdalena ^a   Gumułka, Stanisław Witold ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Hyperalgesia; Opioids; Rats; Selol; Vincristine

Indexed keywords

BUPRENORPHINE; FENTANYL; MORPHINE SULFATE; ORGANOSELENIUM DERIVATIVE; SELOL; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; HYPERALGESIA; MALE; MECHANICAL STIMULATION; MONOTHERAPY; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; RAT; TREATMENT DURATION; WITHDRAWAL REFLEX;

EID: 54349124071     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Aley KO, Reichling DB, Levine JD (1996). Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans. Neuroscience. 73: 259-265.
2. Bujalska M, Malinowska E, Makulska-Nowak H, Gumulka SW (2008a). Magnesium Ions and Opioid Agonist Activity in Streptozotocin-Induced Hyperalgesia. Pharmacology. 82: 180-186.
3. Bujalska M, Tatarkiewicz J, Gumułka SW (2008). Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy. Pharmacology. 81: 158-163.
4. Chabner BA, Allegra CJ, Curt GA, Calabresi P (1996). Antineoplastic agents. In: Goodman and Gilman's, ed. The Pharmacological Basis of Therapeutics. McGraw-Hill. Ed 9, chapter 51, p. 1233-1287.
5. Chung JM (2004). The role of reactive oxygen species (ROS) in persistent pain. Mol Interv. 4: 248-250.
6. Gazda LS, Milligan ED, Hansen MK, Twining CM, Poulos NM, Chacur M, et al (2001). Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. J Peripher Nerv Syst. 6: 111-129.
7. Grover S, Sharma A, Singh M (2000). Role of oxide in diabetes-induced attenuation of antinociceptive effect of morphine in mice. Eur J Pharm. 399: 161-164.
8. Jastrzebski Z, Czyzewska-Szafran H, Fijałek Z, Suchocki P, Fitak BA (1995). Toxicity studies of a new selenium compound, selol, in rats Drugs Exptl Clin Res. 21: 217-220.
9. Jastrzebski Z, Czyzewska-Szafran H, Remiszewska M, Fijałek Z, Fitak BA, Suchocki P (1997). Pharmacokinetics os selol, a new agent containing selenium, in rats. Drugs Exptl Clin Res. 23: 7-11.
10. Khalil Z, Khodr B (2001). A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury. Free Radic Biol Med. 31: 430-439.
11. Khalil Z, Liu T, Helme RD (1999). Free radicals contribute to the reduction in peripheral vascular responses and maintenance of thermal hyperalgesia in rats with chronic constriction injury. Pain 79: 31-37.
12. Kim SH, Johnson VJ, Tae-Yong S, Sharma RP (2004). Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-κB signaling pathways. Exp Biol Med (Maywood). 299: 203-213.
13. Koller LD, Exon JH (1986). The two faces of selenium - deficiency and toxicity - are similar in animals and man. Can J Vet Res. 50: 297-306.
14. Micromedex (2002): Drugdex Drug Evaluations: Vincristine. Monograph in database on CD: "Micromedex® Healthcare Series", Vol 112. Copyright: Micromedex Thomson Health Care.
15. Nogueira CW, Quinhones EB, Jung EA, Zeni G, Roch JB (2003). Anti - inflammatory and antinociceptive of diphenyl diselenide. Inflamm Res. 52: 56-63.
16. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC (2002). Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-κB in up-regulation. Biochem J. 366: 203-209.
17. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA (2003). Anti - hyperalgesic and morphine - sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammaotry cytokines. Pain. 104: 655-664.
18. Randall LO and Selitto JJ (1957). A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 111: 409-419.
19. Rokyta R, Holecek V, Pekárková I, Krejcová J, Racek J, Trefil L, Yamamotová A (2003). Free radicals after painful stimulation are influenced by antioxidants and analgesics. Neuroendocrinol Lett. 24: 304-309.
20. Savegnago L, Jesse CR, Moro AV, Borges VC, Santos FW, Rocha JBT, Nogueira CW (2006). Bis selenide alkane derivatives: A class of potential antioxidant and antinociceptive agents. Pharmacol Biochem. Behav. 83: 221-229.
21. Suchocki P (2007). Podstawowe informacje o preparacie "Selol" [Basic information about "Salol"] www.farm.amwaw.edu.pl/ authority/SELOL.pdf
22. Suchocki P, Jakoniuk D, Fitak BA (2003). Specific spectrophotometric method with trifluoroacetic acid for the determination of selenium(IV) in selenitetriglycerides.; J Pharm Biomed Anal. 32: 1029-1036.
23. Suchocki P, Misiewicz I, Skupińska K, Waławek K, Fijałek Z, Skrzycka-Gutman T (2007). The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncology Reports. 18: 893-899.
24. Tal MA (1996). novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy. Neuroreport. 7: 1382-1384.
25. Tallarida RJ, Murray RB. Manual of Pharmacologic Calculation with Computer Programs (1986), ed 2, New York: Springer, p. 113-117.
26. Tanner KD, Levine JD, Topp KS (1998). Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat. J Comp Neurol. 395: 481-492.
27. Tetsuka T, Baler LD, Morrisom AR (1996). Antioxidants Inhibit Interleukin-1-induced cyclooxygenase and nitric-oxide synthase in rat mesangial cells. J Biol Chem. 271: 11689-11693.
28. Topp KS, Tanner KD, Levine JD. Damage to the cytoskeleton of large diameter sensory neurons and myelinated axons in vincristine-induced painful peripheral neuropathy in the rat. J Comp Neurol 424: 563-576, 2000.
29. Ulugol A, Aslantas A, Tuncer A, Hakan C, Dokmeci I (2002). Combined systemic administration of morphine and magnesium sulfate attenuates pain - related behaviour in mononeuropathic rat. Brain Res. 943: 101-104.
30. Wagner R, Heckman HM, Myers RR (1998). Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent. Pain. 77: 173-179.
31. Xiangqi L, Clark D (2001). Spinal cord nitric oxide synthase and heme oxygenase limit morphine induced analgesia. Molecular Brain Res. 95: 96-102.
32. Yun Ch-H, Yang J S, Kang S, Yang Y, Cho JH, Son ChG, et al (2007). NK-kB signaling pathway, not IFN-Beta/STAT1, is responsible for the selenium suppression of LPS-induced nitric oxide production. Inter Immunopharmacol. 7: 1192-1198.
33. Zamamiri-Davis F, Lu Y, Thompson JT, Prabhu KS, Reddy PV, Sordillo LM, et al (2002). Nuclear factor-kappaB mediates overexpression of cyclooxygenase-2 during activation of RAW 264.7 macrophages in selenium deficiency. Free Radic Biol Med. 32: 890-897.
34. Zurek JR, Nadeson R, Goodchild CS (2001). Spinal and supra-spinal components of opioid antinociception in streptozotocin induced diabetes neropathy in rats. Pain. 90: 57-63.